Matricaria Recutita Extract is a botanical preparation containing a characteristic profile of plant secondary metabolites—alkaloids, flavonoids, terpenoids, phenolic acids, and glycosides—whose combined pharmacological activity determines its therapeutic utility. Chemical variability inherent to botanical materials requires standardisation to defined marker compound concentrations and drug-to-extract ratios to ensure consistent biological activity across batches. Toxicological evaluation of Matricaria Recutita Extract encompasses the full chemical complexity of the preparation, including assessment of individual toxic constituents and any contaminants such as pesticide residues, heavy metals, or mycotoxins.
Reproductive and developmental toxicity findings for Matricaria Recutita Extract receive an additional severity factor consideration in PDE derivation, because pharmaceutical patient populations frequently include women of childbearing potential and, in some indications, pregnant patients.
